Metraipolis › archive › dc_785ef45ea5de

Pregnancy Outcomes After in Utero Exposure to Immune Checkpoint Inhibitors — Europe PMC PMID:42346218

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42346218
DOI
10.3390/curroncol33060318
License (as archived)
solo-consultazione
Archived
2026-11-01T05:22:31.671Z
SHA-256 of the archived text
b19b091bdbcdf369072fcc72f7f4763f6ee665881b420da25c1eb5d0df17c8e3
Stable URL of this page
https://metraipolis.com/documento/dc_785ef45ea5de

How to cite

Pregnancy Outcomes After in Utero Exposure to Immune Checkpoint Inhibitors — Europe PMC PMID:42346218 — Europe PMC (en), https://europepmc.org/article/MED/42346218 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_785ef45ea5de (Metraipolis archive dc_785ef45ea5de, sha256 b19b091bdbcdf369072fcc72f7f4763f6ee665881b420da25c1eb5d0df17c8e3)
BibTeX
@misc{dc785ef45ea5de,
  title = {Pregnancy Outcomes After in Utero Exposure to Immune Checkpoint Inhibitors — Europe PMC PMID:42346218},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42346218},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_785ef45ea5de; sha256 b19b091bdbcdf369072fcc72f7f4763f6ee665881b420da25c1eb5d0df17c8e3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42346218. Agents can read the archived copy with the MCP tool read_document.